FR2429591A1 - Procede et composition de traitement du cancer - Google Patents

Procede et composition de traitement du cancer

Info

Publication number
FR2429591A1
FR2429591A1 FR7819704A FR7819704A FR2429591A1 FR 2429591 A1 FR2429591 A1 FR 2429591A1 FR 7819704 A FR7819704 A FR 7819704A FR 7819704 A FR7819704 A FR 7819704A FR 2429591 A1 FR2429591 A1 FR 2429591A1
Authority
FR
France
Prior art keywords
composition
particles
cancer
treatment method
cancer treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7819704A
Other languages
English (en)
French (fr)
Other versions
FR2429591B1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2429591A1 publication Critical patent/FR2429591A1/fr
Application granted granted Critical
Publication of FR2429591B1 publication Critical patent/FR2429591B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7819704A 1978-06-30 1978-06-30 Procede et composition de traitement du cancer Granted FR2429591A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782828941 DE2828941A1 (de) 1978-06-30 1978-06-30 Mittel zur behandlung von krebs

Publications (2)

Publication Number Publication Date
FR2429591A1 true FR2429591A1 (fr) 1980-01-25
FR2429591B1 FR2429591B1 (cg-RX-API-DMAC10.html) 1981-06-26

Family

ID=6043278

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7819704A Granted FR2429591A1 (fr) 1978-06-30 1978-06-30 Procede et composition de traitement du cancer

Country Status (3)

Country Link
DE (1) DE2828941A1 (cg-RX-API-DMAC10.html)
FR (1) FR2429591A1 (cg-RX-API-DMAC10.html)
GB (1) GB2024007B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508802A1 (fr) * 1981-07-03 1983-01-07 Thomson Csf Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
DE4419256A1 (de) * 1994-06-01 1995-12-07 Rau Freiherr Von Nagell Helmut Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten
EP1067971A1 (en) 1998-04-03 2001-01-17 Du Pont Pharmaceuticals Company Inorganic material for radioactive drug delivery
US11076916B2 (en) 2015-12-23 2021-08-03 Rhode Island Hospital Thermal accelerant compositions and methods of use
US12702478B2 (en) 2015-12-23 2026-08-11 Rhode Island Hospital Devices, methods, and compositions for thermal acceleration and drug delivery
CN108430362A (zh) 2015-12-23 2018-08-21 罗得岛州医院 热促进剂组合物及其使用方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474777A (en) * 1966-02-10 1969-10-28 Amp Inc Method of administering therapeutic agents
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
FR2316974A1 (fr) * 1975-07-11 1977-02-04 Leveen Harry Procede de traitement de tumeurs par diathermie
FR2321305A1 (fr) * 1975-08-04 1977-03-18 Critical Systems Procede et appareil pour chauffer les tissus, notamment pour traitement des tumeurs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294686A (en) * 1966-12-27 Pigment particles coated with organo-alumtnum compounds
DE1284528B (de) * 1967-03-08 1968-12-05 Foerster Einrichtung zur Ausschaltung von biologischem Gewebe durch induktiv erhitzte Koerper mit temperaturstabilisierenden Eigenschaften
DE1692771A1 (de) * 1968-02-24 1972-01-05 Willy Dr Med Seuss Verfahren zur Zubereitung innerlich oder aeusserlich anwendbarer physiologisch wirksamer Stoffe und danach hergestellte Mittel
SE372421B (cg-RX-API-DMAC10.html) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
US3720761A (en) * 1968-10-14 1973-03-13 W Hunter Injectable radio-pharmaceutical scanning agent and preparation
GB1270410A (en) * 1969-09-25 1972-04-12 Allor Corp Colloidal composition and method of preparing the same
US3743714A (en) * 1970-12-04 1973-07-03 Cis Radiopharmaceuticals Inc Novel carrier preparations for injectable radioactive compositions
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
SE431214B (sv) * 1977-06-02 1984-01-23 Klaus H Mosbach Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474777A (en) * 1966-02-10 1969-10-28 Amp Inc Method of administering therapeutic agents
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
FR2316974A1 (fr) * 1975-07-11 1977-02-04 Leveen Harry Procede de traitement de tumeurs par diathermie
FR2321305A1 (fr) * 1975-08-04 1977-03-18 Critical Systems Procede et appareil pour chauffer les tissus, notamment pour traitement des tumeurs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1974 *
NV8021/67 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508802A1 (fr) * 1981-07-03 1983-01-07 Thomson Csf Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede

Also Published As

Publication number Publication date
GB2024007B (en) 1983-04-27
DE2828941A1 (de) 1980-01-10
DE2828941C2 (cg-RX-API-DMAC10.html) 1989-03-16
FR2429591B1 (cg-RX-API-DMAC10.html) 1981-06-26
GB2024007A (en) 1980-01-09

Similar Documents

Publication Publication Date Title
Lasne et al. Two-stage malignant transformation of rat fibroblasts in tissue culture
Busch et al. A nucleolar antigen found in a broad range of human malignant tumor specimens
Bell et al. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test
FR2393795A1 (fr) Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique
FI861150L (fi) Monoklonala antikroppar mot metallkelat.
WO2021207242A3 (en) Anti-mesothelin antigen-binding molecules and uses thereof
BR112022016715A2 (pt) Vetores virais que expressam proteínas terapêuticos especificamente em células mieloides e microglia
Orr et al. Partial characterization of a bone-derived chemotactic factor for tumor cells
CA2144750A1 (en) Tumor-specific antibodies and antigen
Zupancic Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma
Kwon et al. Optimization of magnetic hyperthermia effect for breast cancer stem cell therapy
DE3686811D1 (de) Verfahren und zusammensetzung zur behandlung von krebs und nichtmalignen tumoren.
ES467231A1 (es) Procedimiento y su correspondiente aparato para el trata- miento de metal fundido mediante introduccion de un aditivo de reaccion en el metal fundido.
FR2357514A1 (fr) Nouvelles substances odorantes a odeur de musc et procede pour leur preparation
Wu et al. Biosynthesis of Cu2‐xSe Nanocatalyst Within Probiotics for Repolarization of Tumor Associated Macrophages to Boost Mild Photothermal Sensitized Chemodynamic Immunotherapy
FR2335606A1 (fr) Procede de traitement d'un acier faiblement allie par chauffage et deformation ayant pour but d'ameliorer ses proprietes physiques
IT1264083B1 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
Karewicz et al. Surface-modified SPION systems for cancer therapy
GB619886A (en) Improvements in or relating to the deironing of chromium ores
SU96727A1 (ru) Способ диффузионного насыщени поверхностных слоев металлических изделий
FR2423223A1 (fr) Vaccin et dose a injecter pour l'immunotherapie d'une maladie neoplasique
SU116147A1 (ru) Способ измельчени и электризации частиц синтетического магнетита
Kaszuba-Zwoińska et al. Cell viability changes in cultured H4 glioma cells upon low frequency pulsed electromagnetic field (7Hz, 30mT) exposure in flow cytometry analysis
ES418052A1 (es) Procedimiento y aparato para retirar materiales semejantes de un fluido.
Mues et al. MPI visualization and inductive heating of hybrid implant fibers

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse